Karl‐Dimiter Bissig

5.2k citations

43 papers · 1.8k indexed · h-index 23

Molecular Biology top 10%
Epidemiology top 10%
Hepatology top 2%
Oncology top 10%
Genetics top 10%

Co-authors: Inder M. Verma Tam Thi Le Marc Solioz Stefan Wieland Niels-Bjarne Woods Francis V. Chisari Masanori Isogawa Phu Dac Tran
Topics: CRISPR and Genetic Engineering (11 papers)Hepatitis B Virus Studies (7 papers)Trace Elements in Health (6 papers)
Cited by: Hepatology Business and International Management Aging
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Nature Communications
Partner nations: United States Switzerland Germany

In The Last Decade

Karl‐Dimiter Bissig

42 papers receiving 1.8k citations

Peers

Countries citing papers authored by Karl‐Dimiter Bissig

Since Specialization

Citations

This map shows the geographic impact of Karl‐Dimiter Bissig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Dimiter Bissig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Dimiter Bissig more than expected).

Fields of papers citing papers by Karl‐Dimiter Bissig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐Dimiter Bissig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Dimiter Bissig. The network helps show where Karl‐Dimiter Bissig may publish in the future.

Co-authorship network of co-authors of Karl‐Dimiter Bissig

This figure shows the co-authorship network connecting the top 25 collaborators of Karl‐Dimiter Bissig. A scholar is included among the top collaborators of Karl‐Dimiter Bissig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl‐Dimiter Bissig. Karl‐Dimiter Bissig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa 2025 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Sang-oh Han,Mercedes Barzi,Haiqing Yi,William Eisner,Beatrice Bissig-Choisat,Karl‐Dimiter Bissig,Baodong Sun	0
2	CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I 2025 ·JHEP Reports ·Tong Chen,Mercedes Barzi,(unknown),Hyunjae R. Kim,(unknown),Xavier Legras,Sarah H. Elsea,Ayrea Hurley,Diane Yang,David A. Wheeler,Malgorzata Borowiak,Beatrice Bissig-Choisat,Pavel Sumazin,Karl‐Dimiter Bissig	1
3	A humanized mouse model for adeno-associated viral gene therapy 2024 ·Nature Communications ·Mercedes Barzi,Tong Chen,(unknown),(unknown),(unknown),(unknown),(unknown),Yunhan Ma,(unknown),Sarah E. Woodfield,Anna Mae Diehl,Sanjeev A. Vasudevan,Nhu Thao Nguyen Galván,John A. Goss,Charles A. Gersbach,Beatrice Bissig-Choisat,Aravind Asokan,Karl‐Dimiter Bissig	7
4	Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model 2023 ·Journal of Hepatology ·(unknown),(unknown),Beatrice Bissig-Choisat,Sandra L. Grimm,Xuan Qin,Angela M. Major,Li Yang,Dolores López‐Terrada,Cristian Coarfa,Feng Li,Karl‐Dimiter Bissig,David D. Moore,Loning Fu	31
5	Author Correction: Generation of model tissues with dendritic vascular networks via sacrificial laser-sintered carbohydrate templates 2021 ·Nature Biomedical Engineering ·Ian S. Kinstlinger,Sarah H. Saxton,Gisele A. Calderon,(unknown),(unknown),(unknown),(unknown),(unknown),Fredrik Johansson,(unknown),Daniel W. Sazer,(unknown),Karl‐Dimiter Bissig,Kelly R. Stevens,Jordan S. Miller	2
6	Targeting the Apoa1 locus for liver-directed gene therapy 2021 ·Molecular Therapy — Methods & Clinical Development ·Marco De Giorgi,Ang Li,Ayrea Hurley,Mercedes Barzi,Alexandria M. Doerfler,(unknown),(unknown),Jonathan D. Brown,Charles Y. Lin,Karl‐Dimiter Bissig,Gang Bao,William R. Lagor	14
7	Metabolism of a Selective Serotonin and Norepinephrine Reuptake Inhibitor Duloxetine in Liver Microsomes and Mice 2021 ·Drug Metabolism and Disposition ·Xuan Qin,(unknown),Kevin R. MacKenzie,Mercedes Barzi,Hemantkumar Chavan,Pranavanand Nyshadham,Jin Wang,Sung Yun Jung,(unknown),Si Chen,Lei Guo,Partha Krishnamurthy,Karl‐Dimiter Bissig,Stephen Palmer,Martin M. Matzuk,Feng Li	12
8	Generation of model tissues with dendritic vascular networks via sacrificial laser-sintered carbohydrate templates 2020 ·Nature Biomedical Engineering ·Ian S. Kinstlinger,Sarah H. Saxton,Gisele A. Calderon,(unknown),(unknown),(unknown),(unknown),(unknown),Fredrik Johansson,(unknown),Daniel W. Sazer,(unknown),Karl‐Dimiter Bissig,Kelly R. Stevens,Jordan S. Miller	106
9	PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma 2018 ·Communications Biology ·Leila Valanejad,Ashley Cast,Mary Wright,Karl‐Dimiter Bissig,Rebekah Karns,Matthew T. Weirauch,Nikolai A. Timchenko	29
10	Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing 2018 ·Gastroenterology ·(unknown),Mercedes Barzi,Kang Ho Kim,Xavier Legras,(unknown),Clavia Ruth Wooton‐Kee,William R. Lagor,Juan C. Marini,Sarah H. Elsea,Beatrice Bissig-Choisat,David D. Moore,Karl‐Dimiter Bissig	16
11	P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity 2018 ·Drug Metabolism and Disposition ·Karl‐Dimiter Bissig,Weiguo Han,Mercedes Barzi,(unknown),(unknown),Xiaoyu Fan,(unknown),Qing-Yu Zhang,Xinxin Ding	42
12	A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism 2017 ·Nature Communications ·Mercedes Barzi,(unknown),Barry Zorman,Xing Liu,Xavier Legras,Diane Yang,Malgorzata Borowiak,Beatrice Bissig-Choisat,Pavel Sumazin,Feng Li,Karl‐Dimiter Bissig	27
13	Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice 2015 ·Scientific Reports ·(unknown),Cheng‐Pu Sun,Hui-Hsien Chou,Tzu‐Hui Wu,Chun‐Chi Chen,Ping‐Yi Wu,(unknown),Karl‐Dimiter Bissig,Mi‐Hua Tao	18
14	Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model 2015 ·Nature Communications ·Beatrice Bissig-Choisat,Lili Wang,Xavier Legras,Pradip Saha,Leon Chen,Peter Bell,(unknown),Matthew C. Hill,Mercedes Barzi,(unknown),Hon‐Chiu Eastwood Leung,Robert L. Kruse,Ryan Himes,John A. Goss,James M. Wilson,Lawrence Chan,William R. Lagor,Karl‐Dimiter Bissig	45
15	In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides 2015 ·Journal of Hepatology ·Gaëtan Billioud,Robert L. Kruse,Melissa Carrillo,Christina Whitten-Bauer,Dacao Gao,Aneeza Kim,Leon Chen,Michael L. McCaleb,Jeffrey R. Crosby,Robert Hamatake,Zhi Hong,Urtzi Garaigorta,Eric E. Swayze,Karl‐Dimiter Bissig,Stefan Wieland	42
16	KDR Identifies a Conserved Human and Murine Hepatic Progenitor and Instructs Early Liver Development 2013 ·Cell stem cell ·Orit Goldman,Songyan Han,Marion Sourisseau,Noelle Dziedzic,Wissam Hamou,Barbara Corneo,Sunita L. D’Souza,Thomas T. Sato,Darrell N. Kotton,Karl‐Dimiter Bissig,Tamara Kalir,(unknown),T.E. Evans,Matthew J. Evans,Valerie Gouon–Evans	1
17	A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity 2010 ·Current Biology ·Sergio Ruiz,Athanasia D. Panopoulos,(unknown),Karl‐Dimiter Bissig,Margaret Lutz,W. Travis Berggren,Inder M. Verma,Juan Carlos Izpisúa Belmonte	243
18	Interaction of the CopZ Copper Chaperone with the CopA Copper ATPase of Enterococcus hirae Assessed by Surface Plasmon Resonance 2001 ·Biochemical and Biophysical Research Communications ·Gerd Multhaup,Daniel Strausak,Karl‐Dimiter Bissig,Marc Solioz	55
19	Tetrathiomolybdate inhibition of the Enterococcus hirae CopB copper ATPase 2001 ·FEBS Letters ·Karl‐Dimiter Bissig,(unknown),Marc Solioz	33
20	Expression of the Human Menkes ATPase in Xenopus laevis Oocytes 2001 ·Biological Chemistry ·Karl‐Dimiter Bissig,Sharon La Fontaine,Julian F. B. Mercer,Marc Solioz	7

About Karl‐Dimiter Bissig

Karl‐Dimiter Bissig is a scholar working on Aging, Hepatology and Pharmacology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (11 papers), Hepatitis B Virus Studies (7 papers) and Trace Elements in Health (6 papers). The work is most often cited by research in Hepatology (396 citations), Business and International Management (42 citations) and Aging (34 citations). Karl‐Dimiter Bissig has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Inder M. Verma, Tam Thi Le, Marc Solioz, Stefan Wieland, Niels-Bjarne Woods, Francis V. Chisari, Masanori Isogawa, Phu Dac Tran, Mercedes Barzi and Sergio Ruiz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact